DNB Fund - Biotechnology N (ACC) EUR

WKN A40FC8 | ISIN LU2814038340 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2208649280 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD +16,83 % +22,43 % 0,66
2 LU1540962054 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD +15,87 % +21,11 % 0,66
3 LU0400035332 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD +16,59 % +22,43 % 0,65
4 LU1540961759 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD +14,77 % +19,99 % 0,64
5 LU0069152568 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD +15,40 % +22,42 % 0,60
72 LU2814038340 DNB Fund - Biotechnology N (ACC) EUR +1,86 % +24,22 % -0,01
83 LU1725387622 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating -10,00 % +14,24 % -0,85
84 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating -10,12 % +14,24 % -0,85
85 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating -10,74 % +14,23 % -0,90
86 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -11,23 % +14,56 % -0,91
87 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -11,85 % +14,56 % -0,95